Skip to main content
Equibles

Swiss National Bank

Bank

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 1582202 ZURICH, V8
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$757,746
-$103,070 QoQ
Shares Held
94,600
-11.8% QoQ
Ownership
0.095%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 209 holders
Holding Since
Jun 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,800,323,370 across 152 Biotechnology names. SPRY ranks #145 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 717,440 $356,373,971
2 REGN
Regeneron Pharmaceuticals, Inc.
 293,020 $182,709,690
3 ALNY
Alnylam Pharmaceuticals, Inc.
 374,080 $112,609,302
4 RVMD
Revolution Medicines, Inc.
 456,331 $85,461,669
5 RPRX
Royalty Pharma plc
 1,159,800 $65,029,986
6 INSM
INSMED Inc
 593,512 $63,280,249
7 INCY
Incyte Corp
 476,874 $54,058,436
8 MRNA
Moderna, Inc.
 679,900 $47,613,397

All Filings in SPRY

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $757,746 94,600
2026-03-31 $860,816 107,200
2025-12-31 $1,248,880 107,200
2025-09-30 $847,215 84,300
2025-06-30 $1,471,035 84,300
2025-03-31 $952,306 75,700
2024-12-31 $798,635 75,700
2024-09-30 $1,097,650 75,700
2024-06-30 $561,660 66,000
2024-03-31 $674,520 66,000
2023-12-31 $361,680 66,000
2023-09-30 $311,094 82,300
2023-06-30 $551,410 82,300
2021-09-30 $230,538 23,100
2021-06-30 $713,559 23,100